臺灣癌症登記長表之資料模型

癌症登記之個案確認

1.1 申報醫院代碼（Organization Profile.identifier）

癌症登記之病患資訊

1.2 病歷號碼（Patient Profile.identifier）

1.3 姓名（Patient Profile.name）

1.4 身分證統一編號（Patient Profile.identifier）

1.5 性別（Patient Profile.gender）

1.6 出生日期（Patient Profile.birthDate）

1.7 戶籍地代碼（Patient Profile.address.postalCode）

癌症登記之癌症確認

癌症個案之診斷與分類

2.1 診斷年齡（Condition Profile.onsetAge）

2.2 癌症發生順序號碼（Condition Profile.code）

2.3 個案分類（Condition Profile.category）

2.3.1 診斷狀態分類（Condition Profile.category）

2.3.2 治療狀態分類（Condition Profile.category）

2.5 最初診斷日期（Date Of Diagnosis Condition Profile.onsetPeriod.start）

2.11 癌症確診方式（Condition Profile.evidence）

2.4 首次就診日期（Encounter Profile.period.start）

原發性癌症

2.6 原發部位（Primary Cancer Profile.bodySite）

2.7 側性（Primary Cancer Profile.bodySite）

2.8 組織型態（Primary Cancer Profile.Histology）

2.9 性態碼（Primary Cancer Profile.BehaviorCode）

2.10.1 臨床分級/分化（Grade Clinical Profile.valueCodeableConcept）

2.10.2 病理分級/分化（Grade Pathological Profile.valueCodeableConcept）

2.12 首次顯微鏡檢證實日期（Date Of Diagnosis Condition Profile.onsetDateTime）

2.13 腫瘤大小（Tumor Size Profile.valueQuantity/valueCodeableConcept）

2.13.1 神經侵襲（Perineural Invasion Profile.valueCodeableConcept）

2.13.2 淋巴管或血管侵犯（Lymph Vascular Invasion Profile.valueCodeableConcept）

區域淋巴結

2.14 區域淋巴結檢查數目（Regional Lymph Nodes Examined Profile.valueCodeableConcept）

2.15 區域淋巴結侵犯數目（Regional Lymph Nodes Positive Profile.valueCodeableConcept）

癌症登記之癌症最初診斷期別

診斷性及分期性手術處置

3.1 診斷性及分期性手術處置日期（Surgical Diagnostic And Staging Procedure Profile.performedDateTime）

3.2 外院診斷性及分期性手術處置（Surgical Diagnostic And Staging Procedure At Other Facility Profile.code）

3.3 申報醫院診斷性及分期性手術處置（Surgical Diagnostic And Staging Procedure At Other Facility Profile.code）

臨床分期

3.4 臨床T（Clinical T Profile.valueCodeableConcept）

3.5 臨床N（Clinical N Profile.valueCodeableConcept）

3.6 臨床M（Clinical M Profile.valueCodeableConcept）

3.7 臨床期別組合（Clinical Stage Profile.valueCodeableConcept）

3.19 其他分期系統期別（臨床分期）（Clinical Other Staging Profile.valueCodeableConcept）

3.8 臨床分期字根/字首（Clinical Stage Descriptor Profile.valueCodeableConcept）

病理分期

3.10 病理T（Pathologic T Profile.valueCodeableConcept）

3.11 病理N（Pathologic N Profile.valueCodeableConcept）

3.12 病理M（Pathologic M Profile.valueCodeableConcept）

3.13 病理期別組合（Pathologic Stage Profile.valueCodeableConcept）

3.21 其他分期系統期別（病理分期）（Pathologic Other Staging Profile.valueCodeableConcept）

3.14 病理分期字根/字首（Pathologic Stage Descriptor Profile.valueCodeableConcept）

3.16 AJCC癌症分期版本與章節（Clinical Stage Profile/Pathologic Stage Profile.method）

3.17 其他分期系統（Clinical Other Staging Profile/Pathologic Other Staging Profile.method）

癌症登記之首次療程

4.1 首次療程開始日期（First Course Of Treatment Profile.performedPeriod.start）

4.1.1 首次手術日期（First Surgical Procedure Profile.performedDateTime）

原發部位手術方式

4.1.2 原發部位最確切的手術切除日期（Surgical Procedure Of Primary Site Profile.performedDate）

4.1.3 外院原發部位手術方式（Surgical Procedure Of Primary Site At Other Facility Profile.code）

4.1.4 申報醫院原發部位手術方式（Surgical Procedure Of Primary Site Profile.code）

4.1.4.1 微創手術（Minimally Invasive Surgery Profile.code）

4.1.5 原發部位手術邊緣（Surgical Margins Of The Primary Site Profile.valueCodeableConcept）

4.1.5.1 原發部位手術切緣距離（Surgical Margins Distance Of The Primary Site Profile.valueCodeableConcept）

區域淋巴結手術範圍

4.1.6 外院區域淋巴結手術範圍（Scope Of Regional Lymph Node Surgery At Other Facility Profile.code）

4.1.7 申報醫院區域淋巴結手術範圍（Scope Of Regional Lymph Node Surgery Profile.code）

其他部位手術方式

4.1.8 外院其他部位手術方式（Surgical Procedure Other Site At Other Facility Profile.code）

4.1.9 申報醫院其他部位手術方式（Surgical Procedure Other Site Profile.code）

4.1.10 原發部位未手術原因（Reason For No Surgery Of Primary Site Profile.reasonCode）

放射治療

4.2.1.1 放射治療臨床標靶體積摘要（RT Profile.RTTargetSummary）

4.2.1.2 放射治療儀器（RT Profile.code）

4.2.1.3 放射治療開始日期（RT Profile.performedPeriod.start）

4.2.1.4 放射治療結束日期（RT Profile.performedPeriod.end）

4.2.1.8 放射治療狀態（RT Profile.RTStatus）

4.2.1.5 放射治療與手術順序（Sequence Of Radiotherapy And Surgery Profile.code）

4.2.1.6 區域治療與全身性治療順序（Sequence Of Locoregional Therapy And Systemic Therapy Profile.code）

體外放射治療

4.2.2.1 體外放射治療技術（EBRT Technique Profile.code）

最高放射劑量臨床標靶體積摘要

4.2.2.2.1 最高放射劑量臨床標靶體積（EBRT Technique Profile.CTVH.TargetOfCTVH）

4.2.2.2.2 最高放射劑量臨床標靶體積劑量（EBRT Technique Profile.CTVH.DoseToCTVH）

4.2.2.2.3 最高放射劑量臨床標靶體積治療次數（EBRT Technique Profile.CTVH.NumberOfFractionsToCTVH）

較低放射劑量臨床標靶體積摘要

4.2.2.3.1 較低放射劑量臨床標靶體積（EBRT Technique Profile.CTVL.TargetOfCTVL）

4.2.2.3.2 較低放射劑量臨床標靶體積劑量（EBRT Technique Profile.CTVL.DoseToCTVL）

4.2.2.3.3 較低放射劑量臨床標靶體積治療次數（EBRT Technique Profile.CTVL.NumberOfFractionsToCTVL）

其他放射治療

4.2.3.1 其他放射治療儀器（OtherRTProfile.code））

4.2.3.2 其他放射治療技術（OtherRTProfile.RTTechnique）

4.2.3.3.1 其他放射治療臨床標靶體積（OtherRTProfile.OtherRT.TargetOfCTVH）

4.2.3.3.2 其他放射治療臨床標靶體積劑量（Other RT Profile.OtherRT.DoseToCTVH）

4.2.3.3.3 其他放射治療臨床標靶體積治療次數（Other RT Profile.OtherRT.NumberOfFractionsToCTVH）

4.3.1 全身性治療開始日期（Systemic Therapy Profile.performedDateTime）

化學治療

4.3.2 外院化學治療（Chemotherapy At Other Facility Profile.code）

4.3.3 申報醫院化學治療（Chemotherapy Profile.code）

4.3.4 申報醫院化學治療開始日期（Chemotherapy Profile.performedPeriod.start）

荷爾蒙/類固醇治療

4.3.5 外院荷爾蒙/類固醇治療（Hormone Steroid Therapy At Other Facility Profile.code）

4.3.6 申報醫院荷爾蒙/類固醇治療（Hormone Steroid Therapy Profile.code）

4.3.7 申報醫院荷爾蒙/類固醇治療開始日期（Hormone Steroid Therapy Profile.performedPeriod.start）

免疫治療

4.3.8 外院免疫治療（Immunotherapy At Other Facility Profile.code）

4.3.9 申報醫院免疫治療（Immunotherapy Profile.code）

4.3.10 申報醫院免疫治療開始日期（Immunotherapy Profile.performedPeriod.start）

骨髓/幹細胞移植或內分泌處置

4.3.11 骨髓/幹細胞移植或內分泌處置（Hematologic Transplant And Endocrine Procedure Profile.code）

4.3.12 申報醫院骨髓/幹細胞移植或內分泌處置開始日期（Hematologic Transplant And Endocrine Procedure Profile.performedPeriod.start）

標靶治療

4.3.13 外院標靶治療（​Target Therapy At Other Facility Profile.code）

4.3.14 申報醫院標靶治療（Targeted Therapy Profile.code）

4.3.15 申報醫院標靶治療開始日期（Targeted Therapy Profile.performedPeriod.start）

4.4 申報醫院緩和照護（Palliative Care Profile.code）

其他治療

4.5.1 其他治療（Other Treatment Profile.code）

4.5.2 其他治療開始日期（Other Treatment Profile.performedPeriod.start）

結果

首次復發

5.1 首次復發或癌症狀態追蹤日期（First Recurrence Profile.effectiveDateTime）

5.2 首次復發形式（First Recurrence Profile.valueCodeableConcept）

5.3 最後聯絡或死亡日期（Patient Profile.LastContactOrDeath）

5.4 生存狀態（Patient Profile.deceasedBoolean）

癌症登記之個案行政

6.1 摘錄者（Practitioner Profile.identifier）

癌症登記之其他因子

7.1 身高（Height Profile.valueQuantity/valueCodeableConcept）

7.2 體重（Weight Profile.valueQuantity/valueCodeableConcept）

7.3 吸菸行為（Smoking Behavior Profile.component.valueCodeableConcept）

7.4 嚼檳榔行為（Betel Nut Chewing Behavior Profile.component.valueCodeableConcept）

7.5 喝酒行為（Drinking Behavior Profile.component.valueCodeableConcept）

7.6 首次治療前生活功能狀態評估（Assessment Of Performance Status Before Treatment Profile.code）

癌症登記之癌症部位特定因子

8.1 癌症部位特定因子1（SSF1 Profile.valueCodeableConcept）

8.2 癌症部位特定因子2（SSF2 Profile.valueCodeableConcept）

8.3 癌症部位特定因子3（SSF3 Profile.valueCodeableConcept）

8.4 癌症部位特定因子4（SSF4 Profile.valueCodeableConcept）

8.5 癌症部位特定因子5（SSF5 Profile.valueCodeableConcept）

8.6 癌症部位特定因子6（SSF6 Profile.valueCodeableConcept）

8.7 癌症部位特定因子7（SSF7 Profile.valueCodeableConcept）

8.8 癌症部位特定因子8（SSF8 Profile.valueCodeableConcept）

8.9 癌症部位特定因子9（SSF9 Profile.valueCodeableConcept）

8.10 癌症部位特定因子10（SSF10 Profile.valueCodeableConcept）

臺灣癌症登記長表之資料模型

癌症登記之個案確認

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

1.1 申報醫院代碼（Organization Profile.identifier）

癌症登記之病患資訊

1.2 病歷號碼（Patient Profile.identifier）

1.3 姓名（Patient Profile.name）

1.4 身分證統一編號（Patient Profile.identifier）

1.5 性別（Patient Profile.gender）

1.6 出生日期（Patient Profile.birthDate）

1.7 戶籍地代碼（Patient Profile.address.postalCode）

癌症登記之癌症確認

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

癌症個案之診斷與分類

2.1 診斷年齡（Condition Profile.onsetAge）

2.2 癌症發生順序號碼（Condition Profile.code）

2.3 個案分類（Condition Profile.category）

2.3.1 診斷狀態分類（Condition Profile.category）

2.3.2 治療狀態分類（Condition Profile.category）

2.5 最初診斷日期（Date Of Diagnosis Condition Profile.onsetPeriod.start）

2.11 癌症確診方式（Condition Profile.evidence）

2.4 首次就診日期（Encounter Profile.period.start）

原發性癌症

2.6 原發部位（Primary Cancer Profile.bodySite）

2.7 側性（Primary Cancer Profile.bodySite）

2.8 組織型態（Primary Cancer Profile.Histology）

2.9 性態碼（Primary Cancer Profile.BehaviorCode）

2.10.1 臨床分級/分化（Grade Clinical Profile.valueCodeableConcept）

2.10.2 病理分級/分化（Grade Pathological Profile.valueCodeableConcept）

2.12 首次顯微鏡檢證實日期（Date Of Diagnosis Condition Profile.onsetDateTime）

2.13 腫瘤大小（Tumor Size Profile.valueQuantity/valueCodeableConcept）

2.13.1 神經侵襲（Perineural Invasion Profile.valueCodeableConcept）

2.13.2 淋巴管或血管侵犯（Lymph Vascular Invasion Profile.valueCodeableConcept）

區域淋巴結

2.14 區域淋巴結檢查數目（Regional Lymph Nodes Examined Profile.valueCodeableConcept）

2.15 區域淋巴結侵犯數目（Regional Lymph Nodes Positive Profile.valueCodeableConcept）

癌症登記之癌症最初診斷期別

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

診斷性及分期性手術處置

3.1 診斷性及分期性手術處置日期（Surgical Diagnostic And Staging Procedure Profile.performedDateTime）

3.2 外院診斷性及分期性手術處置（Surgical Diagnostic And Staging Procedure At Other Facility Profile.code）

3.3 申報醫院診斷性及分期性手術處置（Surgical Diagnostic And Staging Procedure At Other Facility Profile.code）

臨床分期

3.4 臨床T（Clinical T Profile.valueCodeableConcept）

3.5 臨床N（Clinical N Profile.valueCodeableConcept）

3.6 臨床M（Clinical M Profile.valueCodeableConcept）

3.7 臨床期別組合（Clinical Stage Profile.valueCodeableConcept）

3.19 其他分期系統期別（臨床分期）（Clinical Other Staging Profile.valueCodeableConcept）

3.8 臨床分期字根/字首（Clinical Stage Descriptor Profile.valueCodeableConcept）

病理分期

3.10 病理T（Pathologic T Profile.valueCodeableConcept）

3.11 病理N（Pathologic N Profile.valueCodeableConcept）

3.12 病理M（Pathologic M Profile.valueCodeableConcept）

3.13 病理期別組合（Pathologic Stage Profile.valueCodeableConcept）

3.21 其他分期系統期別（病理分期）（Pathologic Other Staging Profile.valueCodeableConcept）

3.14 病理分期字根/字首（Pathologic Stage Descriptor Profile.valueCodeableConcept）

3.16 AJCC癌症分期版本與章節（Clinical Stage Profile/Pathologic Stage Profile.method）

3.17 其他分期系統（Clinical Other Staging Profile/Pathologic Other Staging Profile.method）

癌症登記之首次療程

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

4.1 首次療程開始日期（First Course Of Treatment Profile.performedPeriod.start）

4.1.1 首次手術日期（First Surgical Procedure Profile.performedDateTime）

原發部位手術方式

4.1.2 原發部位最確切的手術切除日期（Surgical Procedure Of Primary Site Profile.performedDate）

4.1.3 外院原發部位手術方式（Surgical Procedure Of Primary Site At Other Facility Profile.code）

4.1.4 申報醫院原發部位手術方式（Surgical Procedure Of Primary Site Profile.code）

4.1.4.1 微創手術（Minimally Invasive Surgery Profile.code）

4.1.5 原發部位手術邊緣（Surgical Margins Of The Primary Site Profile.valueCodeableConcept）

4.1.5.1 原發部位手術切緣距離（Surgical Margins Distance Of The Primary Site Profile.valueCodeableConcept）

區域淋巴結手術範圍

4.1.6 外院區域淋巴結手術範圍（Scope Of Regional Lymph Node Surgery At Other Facility Profile.code）

4.1.7 申報醫院區域淋巴結手術範圍（Scope Of Regional Lymph Node Surgery Profile.code）

其他部位手術方式

4.1.8 外院其他部位手術方式（Surgical Procedure Other Site At Other Facility Profile.code）

4.1.9 申報醫院其他部位手術方式（Surgical Procedure Other Site Profile.code）

4.1.10 原發部位未手術原因（Reason For No Surgery Of Primary Site Profile.reasonCode）

放射治療

4.2.1.1 放射治療臨床標靶體積摘要（RT Profile.RTTargetSummary）

4.2.1.2 放射治療儀器（RT Profile.code）

4.2.1.3 放射治療開始日期（RT Profile.performedPeriod.start）

4.2.1.4 放射治療結束日期（RT Profile.performedPeriod.end）

4.2.1.8 放射治療狀態（RT Profile.RTStatus）

4.2.1.5 放射治療與手術順序（Sequence Of Radiotherapy And Surgery Profile.code）

4.2.1.6 區域治療與全身性治療順序（Sequence Of Locoregional Therapy And Systemic Therapy Profile.code）

體外放射治療

4.2.2.1 體外放射治療技術（EBRT Technique Profile.code）

最高放射劑量臨床標靶體積摘要

4.2.2.2.1 最高放射劑量臨床標靶體積（EBRT Technique Profile.CTVH.TargetOfCTVH）

4.2.2.2.2 最高放射劑量臨床標靶體積劑量（EBRT Technique Profile.CTVH.DoseToCTVH）

4.2.2.2.3 最高放射劑量臨床標靶體積治療次數（EBRT Technique Profile.CTVH.NumberOfFractionsToCTVH）

較低放射劑量臨床標靶體積摘要

4.2.2.3.1 較低放射劑量臨床標靶體積（EBRT Technique Profile.CTVL.TargetOfCTVL）

4.2.2.3.2 較低放射劑量臨床標靶體積劑量（EBRT Technique Profile.CTVL.DoseToCTVL）

4.2.2.3.3 較低放射劑量臨床標靶體積治療次數（EBRT Technique Profile.CTVL.NumberOfFractionsToCTVL）

其他放射治療

4.2.3.1 其他放射治療儀器（OtherRTProfile.code））

4.2.3.2 其他放射治療技術（OtherRTProfile.RTTechnique）

4.2.3.3.1 其他放射治療臨床標靶體積（OtherRTProfile.OtherRT.TargetOfCTVH）

4.2.3.3.2 其他放射治療臨床標靶體積劑量（Other RT Profile.OtherRT.DoseToCTVH）

4.2.3.3.3 其他放射治療臨床標靶體積治療次數（Other RT Profile.OtherRT.NumberOfFractionsToCTVH）

4.3.1 全身性治療開始日期（Systemic Therapy Profile.performedDateTime）

化學治療

4.3.2 外院化學治療（Chemotherapy At Other Facility Profile.code）

4.3.3 申報醫院化學治療（Chemotherapy Profile.code）

4.3.4 申報醫院化學治療開始日期（Chemotherapy Profile.performedPeriod.start）

荷爾蒙/類固醇治療

4.3.5 外院荷爾蒙/類固醇治療（Hormone Steroid Therapy At Other Facility Profile.code）

4.3.6 申報醫院荷爾蒙/類固醇治療（Hormone Steroid Therapy Profile.code）

4.3.7 申報醫院荷爾蒙/類固醇治療開始日期（Hormone Steroid Therapy Profile.performedPeriod.start）

免疫治療

4.3.8 外院免疫治療（Immunotherapy At Other Facility Profile.code）

4.3.9 申報醫院免疫治療（Immunotherapy Profile.code）

4.3.10 申報醫院免疫治療開始日期（Immunotherapy Profile.performedPeriod.start）

骨髓/幹細胞移植或內分泌處置

4.3.11 骨髓/幹細胞移植或內分泌處置（Hematologic Transplant And Endocrine Procedure Profile.code）

4.3.12 申報醫院骨髓/幹細胞移植或內分泌處置開始日期（Hematologic Transplant And Endocrine Procedure Profile.performedPeriod.start）

標靶治療

4.3.13 外院標靶治療（​Target Therapy At Other Facility Profile.code）

4.3.14 申報醫院標靶治療（Targeted Therapy Profile.code）

4.3.15 申報醫院標靶治療開始日期（Targeted Therapy Profile.performedPeriod.start）

4.4 申報醫院緩和照護（Palliative Care Profile.code）

其他治療

4.5.1 其他治療（Other Treatment Profile.code）

4.5.2 其他治療開始日期（Other Treatment Profile.performedPeriod.start）

結果

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

首次復發

5.1 首次復發或癌症狀態追蹤日期（First Recurrence Profile.effectiveDateTime）

5.2 首次復發形式（First Recurrence Profile.valueCodeableConcept）

5.3 最後聯絡或死亡日期（Patient Profile.LastContactOrDeath）

5.4 生存狀態（Patient Profile.deceasedBoolean）

癌症登記之個案行政

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

6.1 摘錄者（Practitioner Profile.identifier）

癌症登記之其他因子

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

7.1 身高（Height Profile.valueQuantity/valueCodeableConcept）

7.2 體重（Weight Profile.valueQuantity/valueCodeableConcept）

7.3 吸菸行為（Smoking Behavior Profile.component.valueCodeableConcept）

7.4 嚼檳榔行為（Betel Nut Chewing Behavior Profile.component.valueCodeableConcept）

7.5 喝酒行為（Drinking Behavior Profile.component.valueCodeableConcept）

7.6 首次治療前生活功能狀態評估（Assessment Of Performance Status Before Treatment Profile.code）

癌症登記之癌症部位特定因子

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

8.1 癌症部位特定因子1（SSF1 Profile.valueCodeableConcept）